Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 434039, 6 pages
http://dx.doi.org/10.1155/2015/434039
Clinical Study

The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes

1Medical Faculty, Department of Gastroenterology, Yuzuncu Yil University, 65080 Van, Turkey
2Medical Faculty, Department of Internal Medicine, Yuzuncu Yil University, 65080 Van, Turkey
3Medical Faculty, Department of Pathology, Yuzuncu Yil University, 65080 Van, Turkey
4Dr. Ersin Arslan Public Hospital, Department of Gastroenterology, Gaziantep, Turkey

Received 10 January 2015; Revised 23 February 2015; Accepted 12 March 2015

Academic Editor: Jithinraj Edakkanambeth Varayil

Copyright © 2015 Sehmus Olmez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ferro, B. Peleteiro, M. Malvezzi et al., “Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype,” European Journal of Cancer, vol. 50, no. 7, pp. 1330–1344, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Y. Park, A. Srivastava, G. H. Kim et al., “CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance,” Modern Pathology, vol. 23, no. 1, pp. 54–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. International Agency for Research on Cancer, Schistosomes, Liver Flukes and Helicobacter Pylori, IACR, Lyon, France, 1994.
  5. J. Houghton and T. C. Wang, “Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers,” Gastroenterology, vol. 128, no. 6, pp. 1567–1578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Catalano, R. Labianca, G. D. Beretta, G. Gatta, F. de Braud, and E. Van Cutsem, “Gastric cancer,” Critical Reviews in Oncology/Hematology, vol. 71, no. 2, pp. 127–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” The New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Satoh, K. Kimura, T. Takimoto, and K. Kihira, “A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori,” Helicobacter, vol. 3, no. 4, pp. 236–240, 1998. View at Google Scholar · View at Scopus
  9. L. Zhou, J. J. Y. Sung, S. Lin et al., “A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication,” Chinese Medical Journal, vol. 116, no. 1, pp. 11–14, 2003. View at Google Scholar · View at Scopus
  10. Y.-C. Lee, T. H.-H. Chen, H.-M. Chiu et al., “The benefit of mass eradication of helicobacter pylori infection: a community-based study of gastric cancer prevention,” Gut, vol. 62, no. 5, pp. 676–682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Dinis-Ribeiro, M. Areia, A. C. de Vries et al., “Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED),” Virchows Archiv, vol. 460, no. 1, pp. 19–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Akiyama and N. Uemura, “Intestinal metaplasia subtype and gastric cancer risk,” Journal of Gastroenterology and Hepatology, vol. 24, no. 1, pp. 4–6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Correa, M. B. Piazuelo, and K. T. Wilson, “Pathology of gastric intestinal metaplasia: clinical implications,” American Journal of Gastroenterology, vol. 105, no. 3, pp. 493–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Jass and M. I. Filipe, “A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study,” Histopathology, vol. 3, no. 3, pp. 191–199, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Matsukura, K. Suzuki, T. Kawachi et al., “Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas,” Journal of the National Cancer Institute, vol. 65, no. 2, pp. 231–240, 1980. View at Google Scholar · View at Scopus
  16. S. Yalcin, “Gastric cancer in Turkey—a bridge between West and East,” Gastrointestinal Cancer Research, vol. 3, no. 1, pp. 29–32, 2009. View at Google Scholar · View at Scopus
  17. M. K. Turkdoğan, N. Akman, I. Tuncer et al., “The high prevalence of esophageal and gastric cancers in Eastern Turkey,” Medecine Biologie Environnement, vol. 26, no. 1, pp. 79–84, 1998. View at Google Scholar · View at Scopus
  18. M. I. Filipe, F. Potet, W. V. Bogomoletz et al., “Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres,” Gut, vol. 26, no. 12, pp. 1319–1326, 1985. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Fuccio, R. M. Zagari, M. E. Minardi, and F. Bazzoli, “Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 2, pp. 133–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Correa, “Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society Award lecture on cancer epidemiology and prevention,” Cancer Research, vol. 52, no. 24, pp. 6735–6740, 1992. View at Google Scholar · View at Scopus
  21. A. C. de Vries, N. C. T. van Grieken, C. W. N. Looman et al., “Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands,” Gastroenterology, vol. 134, no. 4, pp. 945–952, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. C. de Vries, J. Haringsma, and E. J. Kuipers, “The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection,” Helicobacter, vol. 12, no. 1, pp. 1–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. Capelle, A. C. de Vries, J. Haringsma et al., “The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis,” Gastrointestinal Endoscopy, vol. 71, no. 7, pp. 1150–1158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. González, J. M. Sanz-Anquela, J. P. Gisbert, and P. Correa, “Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence,” International Journal of Cancer, vol. 133, no. 5, pp. 1023–1032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. W. K. Hirota, M. J. Zuckerman, D. G. Adler et al., “ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract,” Gastrointestinal Endoscopy, vol. 63, no. 4, pp. 570–580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Whiting, A. Sigurdsson, D. C. Rowlands, M. T. Hallissey, and J. W. L. Fielding, “The long term results of endoscopic surveillance of premalignant gastric lesions,” Gut, vol. 50, no. 3, pp. 378–381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Tava, O. Luinetti, M. R. Ghigna et al., “Type or extension of intestinal metaplasia and immature/atypical ‘indefinite-for-dysplasia’ lesions as predictors of gastric neoplasia,” Human Pathology, vol. 37, no. 11, pp. 1489–1497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Zullo, C. Hassan, A. Romiti et al., “Follow-up of intestinal metaplasia in the stomach: when, how and why,” World Journal of Gastrointestinal Oncology, vol. 4, no. 3, pp. 30–36, 2012. View at Publisher · View at Google Scholar
  29. A. Sonnenberg, R. H. Lash, and R. M. Genta, “A national study of Helicobactor pylori infection in gastric biopsy specimens,” Gastroenterology, vol. 139, no. 6, pp. 1894.e2–1901.e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Almouradi, T. Hiatt, and B. Attar, “Gastric intestinal metaplasia in an underserved population in the USA: prevalence, epidemiologic and clinical features,” Gastroenterology Research and Practice, vol. 2013, Article ID 856256, 4 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. N. K. Eriksson, P. A. Kärkkäinen, M. A. Färkkilä, and P. E. T. Arkkila, “Prevalence and distribution of gastric intestinal metaplasia and its subtypes,” Digestive and Liver Disease, vol. 40, no. 5, pp. 355–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Ozdil, A. Sahin, R. Kahraman et al., “Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey,” Hepato-Gastroenterology, vol. 57, no. 104, pp. 1563–1566, 2010. View at Google Scholar · View at Scopus
  33. C. A. González, M. L. Pardo, J. M. R. Liso et al., “Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain,” International Journal of Cancer, vol. 127, no. 11, pp. 2654–2660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. I. Filipe, N. Muñoz, I. Matko et al., “Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia,” International Journal of Cancer, vol. 57, no. 3, pp. 324–329, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Gomez and A. Y. Wang, “Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm,” Gastroenterology & Hepatology, vol. 10, no. 6, pp. 369–378, 2014. View at Google Scholar
  36. P. Correa, “Human gastric carcinogenesis: a multistep and multifactorial process —First American Cancer Society Award lecture on cancer epidemiology and prevention,” Cancer Research, vol. 52, no. 24, pp. 6735–6740, 1992. View at Google Scholar · View at Scopus
  37. P. Galiatsatos, J. Wyse, and A. Szilagyi, “Accuracy of biopsies for Helicobacter pylori in the presence of intestinal metaplasia of the stomach,” The Turkish Journal of Gastroenterology, vol. 25, no. 1, pp. 19–23, 2014. View at Publisher · View at Google Scholar
  38. A. Özden, Ş. Dumlu, and Ö. Dönderici, “Helicobacter pylori infeksiyonunun ülkemizde seroepidemiyolojisi,” Gastroenteroloji, vol. 3, pp. 664–668, 1992. View at Google Scholar
  39. J. Wang, L. Xu, R. Shi et al., “Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis,” Digestion, vol. 83, no. 4, pp. 253–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Ito, K. Haruma, T. Kamada et al., “Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 8, pp. 1449–1456, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Correa, E. T. H. Fontham, J. C. Bravo et al., “Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy,” Journal of the National Cancer Institute, vol. 92, no. 23, pp. 1881–1888, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. A. C. de Vries and E. J. Kuipers, “Epidemiology of premalignant gastric lesions: Implications for the development of screening and surveillance strategies,” Helicobacter, vol. 12, no. 2, pp. 22–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Toyokawa, K.-I. Suwaki, Y. Miyake, M. Nakatsu, and M. Ando, “Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study,” Journal of Gastroenterology and Hepatology, vol. 25, no. 3, pp. 544–547, 2010. View at Publisher · View at Google Scholar · View at Scopus